NCT01464047View on ClinicalTrials.gov

Korean Post-marketing Surveillance for Sprycel®

CompletedOBSERVATIONAL
Enrollment

670

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Leukemia, Myelomonocytic, ChronicLeukemia-Lymphoma
Trial Locations (1)

110-756

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01464047 - Korean Post-marketing Surveillance for Sprycel® | Biotech Hunter | Biotech Hunter